and BRCA1
<p>Olaparib and Pembrolizumab Treatment for <em>BRCA1</em>-Mutated and PD-L1-Positive Intrahepatic Cholangiocarcinoma Recurrence and Metastasis: A Case Report</p>
7
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first- line platinum-based chemotherapy
10
Distinct functions of BRCA1 and BRCA2 in double strand break repair
5
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.
22
Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer
6
Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling
7
BP1, an Isoform of DLX4 Homeoprotein, Negatively Regulates BRCA1 in Sporadic Breast Cancer
12
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
48
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
11
Investigation of a novel +ACA BRCA1 promoter polymorphism and its impact on the breast cancer susceptibility phenotype
147
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank
12
Selected aspects of genetic counselling for BRCA1 mutation carriers
14
Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
13
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1–miR-593-5p–MFF axis
20
Germline <em>BRCA1</em> and <em>BRCA2</em> deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India
12
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1 associated breast cancers
13
“DNA Binding Region” of BRCA1 Affects Genetic Stability through modulating the Intra-S-Phase Checkpoint
11
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.
8
The role of BRCA1 in homologous recombination repair in response to replication stress: significance in tumorigenesis and cancer therapy
14
Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian carcinomas with platinum resistance.
26